Oncolytic rhabdovirus vaccines as an adjuvant to adoptive T cell therapy for paediatric metastatic rhabdomyosarcomas: Precision targeting, expansion and trafficking

溶瘤弹状病毒疫苗作为儿童转移性横纹肌肉瘤过继性 T 细胞疗法的佐剂：精确靶向、扩增和运输

• 批准号: 361580
• 负责人: Zemp Franz J
• 金额: $ 9.83万
• 依托单位: University of Calgary
• 依托单位国家: 加拿大
• 项目类别: Fellowship Programs
• 财政年份: 2016
• 资助国家: 加拿大
• 起止时间: 2016-11-01 至 2019-11-01
• 项目状态: 已结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=361580&lang=en
• 关键词: Cancer; Immunology; Immunotherapy; Oncolytic Viruses; Paediatric Cancer

A childhood cancer diagnosis is a tragic, seemingly unfair, reality for nearly 1000 families in Canada each year. Innovations in treatment have been able to increase the odds of beating a paediatric cancer, but this success is a double edged-sword. Many o

儿童癌症诊断是一个悲惨的，似乎不公平的现实，近1000个家庭在加拿大每年。治疗方面的创新已经能够增加战胜儿科癌症的几率，但这种成功是一把双刃剑。许多o